yan lin

Dr. yan lin


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Fitoterapia
Verified
Journal Article
Closed access
JLJing-Jing Li
Jing-Jing Li
XZXu Zhang
Xu Zhang
XSXiang-Chun Shen
Xiang-Chun Shen
QLQing-De Long
Qing-De Long
CXChang-Yan Xu
Chang-Yan Xu
YLyan lin
yan lin

29 November 2021 in Molecules
Verified
Journal Article
Open access
PDF file
JLJingjing Li
Jingjing Li
YLyan lin
yan lin
LHLei He
Lei He
RORongxiu Ou
Rongxiu Ou
TCTao Chen
Tao Chen
QLQingde Long
Qingde Long
Sophora flavescens is a regularly used traditional Chinese medicine. In an attempt to discover adequate active agents, the isoprenoid flavonoids from S. flavescens were further investigated. In this work, two new compounds (1–2, kurarinol A-B) together with 26 known ones (3–28) were isolated and elucidated on the basis of extensive NMR, UV and MS analyses. Furthermore, the antioxidant activity of all constituents was assessed through ABTS, PTIO and DPPH methodologies and also were evaluated for cytotoxic activity by three tumor cell lines (HepG2, A549 and MCF7) and one human normal cell line (LO2 cells). As a result, a multitude of components revealed significant inhibitory activity. In particular, compound 1–2 (kurarinol A-B), two new flavanonols derivatives, exhibited the most potent ABTS inhibitory activity with IC50 of 1.21 µg/mL and 1.81 µg/mL, respectively. Meanwhile, the new compound 1 demonstrated remarkable cytotoxicity against three cancer cells lines with IC50 values ranging from 7.50–10.55 μM but showed little effect on the normal cell. The two new isoprenoid flavonoids could be promising antioxidant and anti-tumor nature agents.

28 September 2022 in Molecules
Verified
Journal Article
Open access
PDF file
YLyan lin
yan lin
LHLei He
Lei He
XCXing-Jun Chen
Xing-Jun Chen
XZXu Zhang
Xu Zhang
XYXuelong Yan
Xuelong Yan
MHMing-Hui He
Ming-Hui He
Polygonum capitatum, known as “Tou Hua Liao” (Chinese name), is a crucial source of Hmong medicinal plants that has benefited human health for a long time. This folk-medicinal plant is widely distributed in the south-west of China for the treatment of various urologic disorders including urinary tract infections, pyelonephritis, and urinary calculus. The purpose of this paper was to provide a systematic and comprehensive overview of the traditional usages, botany, phytochemistry, pharmacology, pharmacokinetics and clinical applications of this flora. Up until the end of 2022, at least 91 compounds had been reported from P. capitatum, mainly covering the classes of flavonoids, lignanoids, phenols and other components. The compounds and extracts isolated from P. capitatum exhibit a wide range of pharmacological activities, such as anti-inflammatory, antioxidant, antimicrobial, anticancer, analgesic, hypothermic, diuretic and other pharmacological effects. Qualitative and quantitative chemical analyses were also covered. Furthermore, the possible development trends and perspectives for future research on this medicinal plant were also discussed.